Evidence map›Paper›PMID 37265116›Full record

ArticleBrain pathology (Zurich, Switzerland)2023

Report two adult cases of high-grade neuroepithelial neoplasm harbouring EP300::BCOR fusions with comprehensive molecular detection.

Yuqiao Xu, Yanghao Hou, Xiaohong Gao, Jing Li, Dezhi Jiang, Zengshan Li, Peizhen Hu, Yingmei Wang, Yuting Wen, Xiaohong Yao and 5 more

Abstract readLetter
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. CNS Tumor with BCOR/BCORL1 Fusion: A Rare Tumor Entity.International journal of molecular sciences · 2025
    Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yuqiao XuState Key Laboratory of Cancer Biology, Department of Pathology, The Basic Medicine Science and the First Affiliated Hospital of the Air Force Medical University, Xi'an, China.ORCID https://orcid.org/0000-0003-1726-3598
Yanghao HouDepartment of Pathology, Chongqing Medical University, Chongqing, China.
Xiaohong GaoState Key Laboratory of Cancer Biology, Department of Pathology, The Basic Medicine Science and the First Affiliated Hospital of the Air Force Medical University, Xi'an, China.
Jing LiBerry Oncology Corporation, Beijing, China.
Dezhi JiangBerry Oncology Corporation, Beijing, China.
Zengshan LiState Key Laboratory of Cancer Biology, Department of Pathology, The Basic Medicine Science and the First Affiliated Hospital of the Air Force Medical University, Xi'an, China.
Peizhen HuState Key Laboratory of Cancer Biology, Department of Pathology, The Basic Medicine Science and the First Affiliated Hospital of the Air Force Medical University, Xi'an, China.
Yingmei WangState Key Laboratory of Cancer Biology, Department of Pathology, The Basic Medicine Science and the First Affiliated Hospital of the Air Force Medical University, Xi'an, China.
Yuting WenDepartment of Pathology, Ninth Hospital of Xi'an, Xi'an, China.
Xiaohong YaoInstitute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Tao LuoInstitute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Qing LiState Key Laboratory of Cancer Biology, Department of Pathology, The Basic Medicine Science and the First Affiliated Hospital of the Air Force Medical University, Xi'an, China.
Zhenyu KeState Key Laboratory of Cancer Biology, Department of Pathology, The Basic Medicine Science and the First Affiliated Hospital of the Air Force Medical University, Xi'an, China.
Junfeng WuState Key Laboratory of Cancer Biology, Department of Pathology, The Basic Medicine Science and the First Affiliated Hospital of the Air Force Medical University, Xi'an, China.
Zhe WangState Key Laboratory of Cancer Biology, Department of Pathology, The Basic Medicine Science and the First Affiliated Hospital of the Air Force Medical University, Xi'an, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37265116
PMCPMC10580003

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.